DermTech, Inc. (DMTKQ) vs iSpecimen Inc. (ISPC)
- DermTech, Inc. DMTKQ 0.00 NaN
- iSpecimen Inc. ISPC 0.92 −10.68%
DermTech, Inc. and iSpecimen Inc. are both Diagnostics & Research companies. DermTech, Inc. is the larger, with a market value of $3.3M against $2.6M — 1.3× the size. DermTech, Inc. grew revenue faster over the last twelve months: 9.71% against −92.1%. DermTech, Inc. has the higher net margin (−572.2% vs −2,449.0%) and the lower return on invested capital (−5,493.5% vs 0.00%). Across the 17 metrics below, DermTech, Inc. leads on 13 and iSpecimen Inc. on 4.
Valuation
Profitability
| Metric | DMTKQ | ISPC | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 8.51% | (108.26%) | 50.89% |
| Operating margin | (588.62%) | (2,020.05%) | (8.57%) |
| Net margin | (572.19%) | (2,449.02%) | (6.37%) |
| Free cash flow margin | (460.10%) | (1,866.61%) | 0.00% |
| Return on equity | (121.75%) | (968.44%) | (2.92%) |
| Return on assets | (64.00%) | (170.09%) | (6.71%) |
| Return on invested capital | (5,493.45%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack